← SynDRA
ALISERTIB
SynDRA canonical compound SYN0018867 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
| Primary target(s) | AURKA |
| Mechanism of action | Aurora kinase inhibitor |
All known targets
Mechanisms of action (all sources)
- aurora kinase inhibitor
- AURKA INHIBITOR
- Serine/threonine-protein kinase Aurora-A inhibitor
Cross-references
Synonyms
- MLN-8237
- ALISERTIB (MLN8237)
- Alisertib sodium
- CHEMBL483158
- MLN-8237-004
- MLN8237
- MLN 8237
- MLN8237 (Alisertib)
- 4-((9-Chloro-7-(2-fluoro-6-methoxyphenyl)-5H-benzo[c]pyrimido[4,5-e]azepin-2-yl)amino)-2-methoxybenzoic acid
- Alisertib [USAN]
- 4-[[9-Chloro-7-(2-fluoro-6-methoxyphenyl)-5H-pyrimido[5,4-d][2]benzazepin-2-yl]amino]-2-methoxybenzoic acid
- T66ES73M18
- Alisertib (USAN)
- 4-((9-Chloro-7-(2-fluoro-6-methoxyphenyl)-5H-benzo[c]pyrimido-[4,5-e]azepin-2-yl)amino)-2-methoxybenzoic acid
- 4-{[9-chloro-7-(2-fluoro-6-methoxyphenyl) -5H-pyrimido[5,4-d][2]benzazepin-2-yl]amino}-2-methoxybenzoic acid
- Benzoic acid, 4-((9-chloro-7-(2-fluoro-6-methoxyphenyl)-5H-pyrimido(5,4-d)(2)benzazepin-2-yl)amino)-2-methoxy-
- Alisertib [USAN:INN]
- UNII-T66ES73M18
- MLN8237,Alisertib
- Kinome_3770
- ALISERTIB [INN]
- Alisertib; MLN8237
- Alisertib (MLN8237)
- MLN8237 - Alisertib
- ALISERTIB [WHO-DD]
- MLS006011041
- SCHEMBL855823
- GTPL7790
- DTXSID30145539
- EX-A024
- MIN8237
- CHEBI:125628
- HMS3654E08
- HMS3673I07
- HMS3743E17
- AMY24201
- BCP01823
- BDBM50277545
Look up ALISERTIB in the interactive SynDRA portal →